86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03270332 (ClinicalTrials.gov)	October 5, 2017	30/8/2017	Effect of Inhaled Albuterol in Pulmonary Hypertension	Effect of Inhaled Albuterol on Pulmonary Hemodynamics in Patients With Group 1 Pulmonary Arterial Hypertension on Oral Pulmonary Vasodilator Therapy: A Proof of Concept Study	Pulmonary Hypertension	Drug: Albuterol;Drug: Placebo	University of Miami	NULL	Completed	18 Years	N/A	All	10	Phase 2	United States
2	NCT02108743 (ClinicalTrials.gov)	June 2014	7/4/2014	Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension	Albuterol and Dynamic Hyperinflation in Idiopathic Pulmonary Arterial Hypertension	Idiopathic Pulmonary Arterial Hypertension.	Drug: Albuterol .;Drug: Normal saline placebo	American Medical Association Foundation	NULL	Withdrawn	18 Years	75 Years	Both	0	Phase 2	United States